Anti-CD20 monoclonal antibody (rituximab) therapy in chronic immune thrombocytopenic purpura;Kronik immün trombositopenik purpurada anti-CD20 monoklonal antikor (rituksimab) tedavisi

Cocuk Sagligi ve Hastaliklari Dergisi

Volumn 49, Issue 2, 2006, Pages 90-95

  Akarsu, Saadet ^a   Kurt, Abdullah ^a   Çitak Kurt, A Neşe ^a   Aydin, Mustafa ^a   Yilmaz, Erdal ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

Anti CD20; Children; Chronic immune thrombocytopenic purpura; Rituximab

Indexed keywords

CD20 ANTIBODY; FC RECEPTOR; RITUXIMAB; THROMBOCYTE FACTOR 1;

ABSENCE OF SIDE EFFECTS; ARTICLE; B LYMPHOCYTE; BACTERIAL INFECTION; CASE REPORT; CHILD; DOSE RESPONSE; DRUG SAFETY; FLOW CYTOMETRY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; THROMBOCYTE COUNT;

EID: 33745796863     PISSN: 00100161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Koulova L, Alexandrescu D, Dutcher JP, O'Boyle KP, Eapen S, Wiernik PH. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases. Am J Hematol 2005; 78: 49-54.
2. Pusiol A, Cesaro S, Nocerino A, Picco G, Zanesco L, Bisogno G. Successful treatment with the monoclonal antibody rituximab in two children with refractory autoimmune thrombocytopenia. Eur J Pediatr 2004; 163: 305-307.
3. Cooper N, Stasi R, Cunningham-Rundles S, et al. The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura. Br J Haematol 2004; 125: 232-239.
4. Binstadt BA, Caldas AM, Turvey SE, et al. Rituximab therapy for multisystem autoimmune diseases in pediatric patients. J Pediatr 2003; 143: 598-604.
5. Thude H, Gruhn B, Werner U, et al. Treatment of a patient with chronic immune thrombocytopenic purpura with rituximab and monitoring by flow cytometric analysis. Acta Haematol 2004; 111: 221-224.
6. Delgado J, Bustos JG, Jimanes-Yuste V, Hernandez-Navarro F. Anti-CD20 monoclonal antibody therapy in refractory immune thrombocytopenic purpura. Haematologica 2002; 87: 215-216.
7. Stasi R, Pagano A, Stipa E, Amadori S. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic pupura. Blood 2001; 98: 952-957.
8. th ed) Vol 2. Philadelphia: WB Saunders, 2003: 1608.
9. rd ed). Boston: Academic Press, 2000: 233-250.
10. Russo G, Licciardello M, La Spina M. Rituximab in children with idiopathic thrombocytopenic purpura: does it really work? Eur J Pediatr 2004; 163: 569.
11. ten Gate R, Smiers FJ, Bredius RG, et al. Anti-CD20 monoclonal antibody (rituximab) for refractory autoimmune thrombocytopenia in a girl with systemic lupus erythematosus. Rheumatology (Oxford) 2004; 43: 244.
12. Wang J, Wiley JM, Luddy R, Greenberg J, Feuerstein MA, Bussel JB. Chronic immune thrombocytopenic purpura in children: assessment of rituximab treatment. J Pediatr 2005; 146: 217-221.
13. Vesely SK, Perdue JJ, Rizvi MA, Terrell DR, George JN. Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy. Ann Intern Med 2004; 140: 112-120.
14. Zaja F, Iacona I, Masolini P, et al. B cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia. Haematologica 2002; 87: 189-195.
15. Zaja F, Vianelli N, Sperotto A, et al. The B-cell compartment as the selective target for the treatment of immune thrombocytopenias. Haematologica 2003; 88: 538-546.
16. Giagounidis A, Anhuf J, Schneider P, et al. Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot study. Eur J Haematol 2002; 69: 95-100.
17. Saleh MN, Gutheil J, Moore M, et al. A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia. Semin Oncol 2000; 27: 99-103.
18. Ahrens N, Heymann G, Meyer O, Kiesewetter H, Salama A. Results of treatment with rituximab (anti-CD20) in three patients with autoimmune hemolytic anemia and/or immune thrombocytopenia and a concise review of reported cases. Infus Ther Transfus 2002; 29: 277-281.
19. Perotta A, Sunnemberg JS, Ratanatharathorn V. Rituxan in the treatment of chronic idiopathic thrombocytopenia purpura. Blood 1999; 94: 49a [abstract].
20. Mow M, Hook CC. Rituximab for the treatment of refractory immune thrombocytopenic purpura. Blood 2000; 96: 3526a [abstract].